CD22 and acute lymphoblastic leukemia: TCR gene transfer installed CD22 reactivity onto recipient T-cells which recognized and lysed CD22-expressing primary ALL samples, ALL cell lines, and B-cells, while sparing healthy nonhematopoietic and hematopoietic cell subsets.